Study of a new cholesterol drug in healthy adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- Your body mass index (BMI) is between 18 and 28 (a measure of weight versus height).
- Your 'bad' cholesterol (LDL-C) is between 1.8 and 4.1 mmol/L, and your triglycerides (another blood fat) are below 4.5 mmol/L.
- You do not have diabetes.
- You have not taken any prescription medications in the last 14 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
This trial tests an experimental medication called QLC7401 for people with a genetic condition that causes very high cholesterol. It aims to lower cholesterol levels safely and may be an option for those who need better control.
This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.
This study tests a combination of two new medications (QCZ484 and inclisiran) designed to lower both blood pressure and cholesterol levels. You may be a good fit if you have high blood pressure and high cholesterol that isn't fully controlled by current treatments.
Hear when a new Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.